96 related articles for article (PubMed ID: 23965518)
1. The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis.
Monti M; Terzuoli E; Ziche M; Morbidelli L
Pharmacol Res; 2013 Oct; 76():171-81. PubMed ID: 23965518
[TBL] [Abstract][Full Text] [Related]
2. Sulfhydryl angiotensin-converting enzyme inhibitor promotes endothelial cell survival through nitric-oxide synthase, fibroblast growth factor-2, and telomerase cross-talk.
Donnini S; Terzuoli E; Ziche M; Morbidelli L
J Pharmacol Exp Ther; 2010 Mar; 332(3):776-84. PubMed ID: 19959747
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor-2 mediates Angiotensin-converting enzyme inhibitor-induced angiogenesis in coronary endothelium.
Donnini S; Solito R; Giachetti A; Granger HJ; Ziche M; Morbidelli L
J Pharmacol Exp Ther; 2006 Nov; 319(2):515-22. PubMed ID: 16868034
[TBL] [Abstract][Full Text] [Related]
4. Characterization of zofenoprilat as an inducer of functional angiogenesis through increased H2 S availability.
Terzuoli E; Monti M; Vellecco V; Bucci M; Cirino G; Ziche M; Morbidelli L
Br J Pharmacol; 2015 Jun; 172(12):2961-73. PubMed ID: 25631232
[TBL] [Abstract][Full Text] [Related]
5. H
Monti M; Terzuoli E; Ziche M; Morbidelli L
Pharmacol Res; 2016 Nov; 113(Pt A):426-437. PubMed ID: 27650753
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting-enzyme inhibition counteracts angiotensin II-mediated endothelial cell dysfunction by modulating the p38/SirT1 axis.
Marampon F; Gravina GL; Scarsella L; Festuccia C; Lovat F; Ciccarelli C; Zani BM; Polidoro L; Grassi D; Desideri G; Evangelista S; Ferri C
J Hypertens; 2013 Oct; 31(10):1972-83. PubMed ID: 23868084
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibiting reactive oxygen species-activated extracellular signal-regulated kinase 1/2 in H9c2 cardiac myocytes.
Liu MH; Lin XL; Zhang Y; He J; Tan TP; Wu SJ; Liu J; Tian W; Chen L; Yu S; Li J; Yuan C
Mol Med Rep; 2015 Nov; 12(5):6841-8. PubMed ID: 26299281
[TBL] [Abstract][Full Text] [Related]
8. Coronary vasodilation induced by captopril and zofenoprilat: evidence for a prostaglandin-independent mechanism.
van Wijngaarden J; Tio RA; van Gilst WH; de Graeff PA; de Langen CD; Wesseling H
Naunyn Schmiedebergs Arch Pharmacol; 1991 May; 343(5):491-5. PubMed ID: 1881459
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition.
Bucci M; Vellecco V; Cantalupo A; Brancaleone V; Zhou Z; Evangelista S; Calderone V; Papapetropoulos A; Cirino G
Cardiovasc Res; 2014 Apr; 102(1):138-47. PubMed ID: 24501330
[TBL] [Abstract][Full Text] [Related]
10. Effects of converting enzyme inhibition on endothelial bradykinin metabolism and endothelium-dependent vascular relaxation.
Bossaller C; Auch-Schwelk W; Gräfe M; Graf K; Baumgarten C; Fleck E
Agents Actions Suppl; 1992; 38 ( Pt 3)():171-7. PubMed ID: 1334349
[TBL] [Abstract][Full Text] [Related]
11. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibitor captopril reverses the adverse cardiovascular effects of polymerized hemoglobin.
Li T; Zhou R; Yao Y; Yang Q; Zhou C; Wu W; Li Q; You Z; Zhao X; Yang L; Li C; Zhu D; Qiu Y; Luo M; Tan Z; Li H; Chen Y; Gong G; Feng Y; Dian K; Liu J
Antioxid Redox Signal; 2014 Nov; 21(15):2095-108. PubMed ID: 24483164
[TBL] [Abstract][Full Text] [Related]
13. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
[TBL] [Abstract][Full Text] [Related]
14. Anticancer drugs induce necrosis of human endothelial cells involving both oncosis and apoptosis.
Mailloux A; Grenet K; Bruneel A; Bénéteau-Burnat B; Vaubourdolle M; Baudin B
Eur J Cell Biol; 2001 Jun; 80(6):442-9. PubMed ID: 11484935
[TBL] [Abstract][Full Text] [Related]
15. Activation of AMP-activated protein kinase contributes to doxorubicin-induced cell death and apoptosis in cultured myocardial H9c2 cells.
Chen MB; Wu XY; Gu JH; Guo QT; Shen WX; Lu PH
Cell Biochem Biophys; 2011 Jul; 60(3):311-22. PubMed ID: 21274754
[TBL] [Abstract][Full Text] [Related]
16. Effect of captopril on doxorubicin-induced nephrotoxicity in normal rats.
Mansour MA; El-Kashef HA; Al-Shabanah OA
Pharmacol Res; 1999 Mar; 39(3):233-7. PubMed ID: 10094850
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity.
Ibrahim MA; Ashour OM; Ibrahim YF; El-Bitar HI; Gomaa W; Abdel-Rahim SR
Pharmacol Res; 2009 Nov; 60(5):373-81. PubMed ID: 19467331
[TBL] [Abstract][Full Text] [Related]
18. The effect of bradykinin on coronary flow and its potentiation by SH-containing ACE-inhibitors.
de Graeff PA; van Gilst WH
Agents Actions Suppl; 1992; 38 ( Pt 3)():110-8. PubMed ID: 1462853
[TBL] [Abstract][Full Text] [Related]
19. Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis.
Zhang L; Yu D; Hicklin DJ; Hannay JA; Ellis LM; Pollock RE
Cancer Res; 2002 Apr; 62(7):2034-42. PubMed ID: 11929822
[TBL] [Abstract][Full Text] [Related]
20. The protective role of arjunolic acid against doxorubicin induced intracellular ROS dependent JNK-p38 and p53-mediated cardiac apoptosis.
Ghosh J; Das J; Manna P; Sil PC
Biomaterials; 2011 Jul; 32(21):4857-66. PubMed ID: 21486680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
